There Is No Association between MicroRNA Gene Polymorphisms and Risk of Triple Negative Breast Cancer in a Chinese Han Population

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Ma, Fei ^a   Zhang, Ping ^a   Lin, Dongxin ^a   Yu, Dianke ^a   Yuan, Peng ^a   Wang, Jiayu ^a   Fan, Yin ^a   Xu, Binghe ^a  

^a CANCER HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC DATABASE; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; POPULATION RISK; RNA ANALYSIS; RNA GENE; SINGLE NUCLEOTIDE POLYMORPHISM; TRIPLE NEGATIVE BREAST CANCER;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENOTYPE; HUMANS; MICRORNAS; MIDDLE AGED; MUTATION; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; YOUNG ADULT;

EID: 84875475735     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060195     Document Type: Article

References (38)

1. Bauer KR, Brown M, Cress RD, Parise CA, Caggiano V, (2007) Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry. Cancer 109(9): 1721-1728.
2. Irvin WJ Jr, Carey LA, (2008) What is triple-negative breast cancer? Eur J Cancer 44(18): 2799-2805.
3. Pal SK, Childs BH, Pegram M, (2011) Triple negative breast cancer: unmet medical needs. Breast Cancer Res Treat 125(3): 627-636.
4. Foulkes WD, Smith IE, Reis-Filho JS, (2010) Triple-negative breast cancer. N Engl J Med 363(20): 1938-1948.
5. Amirikia KC, Mills P, Bush J, Newman LA, (2011) Higher population-based incidence rates of triple-negative breast cancer among young African-American women: Implications for breast cancer screening recommendations. Cancer 117(12): 2747-2753.
6. Cleator S, Heller W, Coombes RC, (2007) Triple-negative breast cancer: therapeutic options. Lancet Oncol 8(3): 235-244.
7. Perez EA, Moreno-Aspitia A, Aubrey Thompson E, Andorfer CA, (2010) Adjuvant therapy of triple negative breast cancer. Breast Cancer Res Treat 120(2): 285-291.
8. Ma K, Chau WW, Wong CH, Wong K, Fung N, et al. (2012) Triple Negative Status is a Poor Prognostic Indicator in Chinese Women with Breast Cancer: a Ten Year Review. Asian Pac J Cancer Prev 13(5): 2109-2114.
9. Morris GJ, Naidu S, Topham AK, Guiles F, Xu Y, et al. (2007) Differences in breast carcinoma characteristics in newly diagnosed African-American and Caucasian patients: a single-institution compilation compared with the National Cancer Institute's Surveillance, Epidemiology, and End Results database. Cancer 110(4): 876-884.
10. Zeng Y, Wagner EJ, Cullen BR, (2002) Both natural and designed micro RNAs can inhibit the expression of cognate mRNAs when expressed in human cells. Mol Cell 9(6): 1327-1333.
11. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, et al. (2004) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A 101(9): 2999-3004.
12. Farazi TA, Spitzer JI, Morozov P, Tuschl T, (2011) miRNAs in human cancer. J Pathol 223(2): 102-115.
13. He L, He X, Lim LP, de Stanchina E, Xuan Z, et al. (2007) A microRNA component of the p53 tumour suppressor network. Nature 447(7148): 1130-1134.
14. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, et al. (2005) MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65(16): 7065-7070.
15. Adams BD, Furneaux H, White BA, (2007) The micro-ribonucleic acid (miRNA) miR-206 targets the human estrogen receptor-alpha (ERalpha) and represses ERalpha messenger RNA and protein expression in breast cancer cell lines. Mol Endocrinol 21(5): 1132-1147.
16. Matthew A Saunders, Han Liang, Wen-Hsiung Li, (2007) Human polymorphism at microRNAs and microRNA target sites. Proc Natl Acad Sci U S A 104(9): 3300-3305.
17. Duan R, Pak CH, Jin P, (2007) Single nucleotide polymorphism associated with mature miR-125a alters the processing of pri-miRNA. Hum Mol Genet 16 (9): 1124-1131.
18. Nicoloso MS, Sun H, Spizzo R, Kim H, Wickramasinghe P, et al. (2010) Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility. Cancer Res 70(7): 2789-2798.
19. Ye Y, Wang KK, Gu J, Yang H, Lin J, et al. (2008) Genetic variations in microRNA-related genes are novel susceptibility loci for esophageal cancer risk. Cancer Prev Res (Phila) 1(6): 460-469.
20. Chin LJ, Ratner E, Leng S, Zhai R, Nallur S, et al. (2008) A SNP in a let-7 microRNA complementary site in the KRAS 3′ untranslated region increases non-small cell lung cancer risk. Cancer Res 68(20): 8535-8540.
21. Horikawa Y, Wood CG, Yang H, Zhao H, Ye Y, et al. (2008) Single nucleotide polymorphisms of microRNA machinery genes modify the risk of renal cell carcinoma. Clin Cancer Res 14(23): 7956-7962.
22. Yang H, Dinney CP, Ye Y, Zhu Y, Grossman HB, et al. (2008) Evaluation of genetic variants in microRNA-related genes and risk of bladder cancer. Cancer Res 68(7): 2530-2537.
23. Hu Z, Liang J, Wang Z, Tian T, Zhou X, et al. (2009) Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women. Hum Mutat 30(1): 79-84.
24. Yang R, Schlehe B, Hemminki K, Sutter C, Bugert P, et al. (2010) A genetic variant in the pre-miR-27a oncogene is associated with a reduced familial breast cancer risk. Breast Cancer Res Treat 121(3): 693-702.
25. Shi YY, He L, (2005) SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 15(2): 97-98.
26. Diederichs S, Haber DA, (2005) Sequence variations of microRNAs in human cancer: alterations in predicted secondary structure do not affect processing. Cancer Res 66(12): 6097-6104.
27. Iwai N, Naraba H, (2005) Polymorphisms in human pre-miRNAs. Biochem Biophys Res Commun 331(4): 1439-1444.
28. Nicoloso MS, Sun H, Spizzo R, Kim H, Wickramasinghe P, et al (2010) Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility. Cancer Res 70(7): 2789-2798.
29. Liang D, Meyer L, Chang DW, Lin J, Pu X, et al. (2010) Genetic variants in MicroRNA biosynthesis pathways and binding sites modify ovarian cancer risk, survival, and treatment response. Cancer Res 70(23): 9765-9776.
30. Hayashita Y, Osada H, Tatematsu Y, Yamada H, Yanagisawa K, et al. (2005) A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 65(21): 9628-9632.
31. Ota A, Tagawa H, Karnan S, Tsuzuki S, Karpas A, et al. (2004) Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. Cancer Res 64(9): 3087-3095.
32. Rinaldi A, Poretti G, Kwee I, Zucca E, Catapano CV, et al. (2007) Concomitant MYC and microRNA cluster miR-17-92 (C13orf25) amplification in human mantle cell lymphoma. Leuk Lymphoma 48(2): 410-412.
33. Tagawa H, Karube K, Tsuzuki S, Ohshima K, Seto M, (2007) Synergistic action of the microRNA-17 polycistron and Myc in aggressive cancer development. Cancer Sci 98(9): 1482-1490.
34. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, et al. (2002) Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 99(24): 15524-15529.
35. Chang TC, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, et al. (2007) Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 26(5): 745-752.
36. Raver-Shapira N, Marciano E, Meiri E, Spector Y, Rosenfeld N, et al. (2007) Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell 26(5): 731-743.
37. Tarasov V, Jung P, Verdoodt B, Lodygin D, Epanchintsev A, et al. (2007) Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle 6(13): 1586-1593.
38. Wang TY, Dong YY, Li HY, Li X, (2010) Molecular evolution and regulatory mechanism of microRNAs. HEREDITAS 32(9): 874-880.